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CC BY-NC-ND license (http://creativeAbstract Objective: To explore whether the traditional Chinese medicine (TCM) Bu Jing Yi
Shi Tablets alters the expression of scleral TGF-b1 and Smad3 in guinea pigs with form-
deprivation myopia (FDM).
Methods: Sixty-five guinea pigs were randomly divided into control, model, low-, medium-,
and high-dose treatment groups. Except for the control group, FDM was induced by covering
the right eye of each animal with opaque latex. The treatment groups were gavaged with
different suspension concentrations of Bu Jing Yi Shi Tablets. Refraction and axial length were
performed before and after myopia induction. At the end of the experiment, all right eyes
were extracted, and scleral sections were prepared for staining and TGF-b1 and Smad3 immu-
nohistochemistry. Scleral thickness and area, the scleral fibroblast quantity, and scleral TGF-
b1 and Smad3 expressions were measured.
Results: The 5 FDM groups had the same initial axial length and diopter, the final diopter and
axial length of the model group were significantly increased compared with the control group
and treatment groups (P < .01). The axial length of each treatment group decreased as the
dose decreased compared with the model group (P < .01); the total scleral area (P < .05
e.01) and the number of scleral fibroblasts (P < .01) in the model group were significantly
lower than the treatment groups. Both the TGF-b1 and Smad3 integral optical densities in
the model group were significantly lower than the control and medium- and high-dose treat-
ment groups (P < .01). TGF-b1 and Smad3 mRNAs in the model group were decreased compared
with the control group, but increased in expression after treatment.(Y. Mo).
f Beijing University of Chinese Medicine.
to this work.
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f Chinese Medicine. Production and hosting by Elsevier B.V. This is an open access article under the
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Scleral TGF-b1 and Smad3 expression 125Conclusion: Bu Jing Yi Shi Tablets may restore the expression of scleral TGF-b1 and Smad3 in
FDM guinea pigs and impede myopia development.
ª 2016 Beijing University of Chinese Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
Myopia is more common in Asian populations than in other
ethnic groups and has become a major public health
problem in China. The prevalence of myopia in elementary
students in Beijing is 31.1%, 62.1% in middle school stu-
dents, and up to 77.9% in high school students.1 This is a
concern because myopia may deteriorate to pathological
myopia in advanced age and be complicated by choroidal
neovascularization2 high myopic maculopathy,3 glaucoma,4
or even retinal detachment.5 Therefore, myopia should be
prevented and treated as early as possible.
The multifunctional cytokine transforming growth
factor b1 (TGF-b1) regulates the remodeling of the scleral
extracellular matrix (ECM) during the development of
myopia. The TGF-b/Smad signaling pathway is required for
both epithelial to mesenchymal transition and trans-
differentiation and fibrosis in a variety of organs.6 Smad3 is
an important factor for TGF-b1 signal transduction, and
drugs that regulate scleral TGF-b1 and Smad3 could be used
to prevent and control myopia. Studies have suggested that
by promoting blood circulation, the traditional Chinese
medicine (TCM) Bu Jing Yi Shi (Tonify the Essence to Benefit
Vision) Tablets confers protective effects on visual perfor-
mance in patients with highmyopia,7 improve visual function
in high myopia after retinal detachment, repairs,8 and even
improve the vision of high myopia patients to some degree.9
Bu Jing Yi Shi formula is comprised of the following
herbs: Lycium fruit (Lycium barbarum L.), Cuscuta seed
(Cuscuta chinensis Lam.), Plantago seed (Plantago asiatica
L.), Salvia root (Salviae miltiorrhizae Bunge), notoginseng
root [Panax notoginseng (Burkill) F.H. Chen], and green
tangerine peel (Citrus reticulata Blanco). The TCM action
of the formula is to nourish the liver and kidneys, improve
eyesight, and tonify essence.
This study investigated whether Bu Jing Yi Shi Tablets
could improve guinea pig FDM by regulating scleral TGF-b1
and Smad3.Materials and methods
Laboratory animals and groupings
Sixty-five healthy 3-week-old male and female guinea pigs
weighing 180e220 g were provided by the Sichuan Labo-
ratory Animal Special Committee (Chengdu, Sichuan,
China). A random number table was used to assign animals
to the following 5 groups of 13 animals each: control,
model, low-, medium-, and high-dose therapy groups. The
animals were housed at 22Ce28C under natural light/
dark cycle with consistent ventilation, noise levels, andwere provided with tap water, fresh vegetables, and
standard guinea pig chow.
All procedures were approved by the Animal Care and
Ethics Committee at Chengdu University of TCM (Chengdu,
China) followed the requirements stated by the Association
for Research in Vision and Ophthalmology (ARVO).
Experimental protocol and induction of form-
deprivation myopia
The experimental period was 1 month. Ocular biometry was
performed in all animals at baseline and at the conclusion
of the experiment.
FDM was induced in all animals except the control group.
Induction was per method described by Zhao et al.10
Briefly, a facemask was fashioned from opaque latex cut
from a balloon. The mask was slipped over the head of the
guinea pig to cover the right eye. The left eye, nose, lips,
and both ears remained exposed. The masks were checked
regularly to ensure they remained in proper position.
A 1 mL suspension of Bu Jing Yi Shi Tablets (Pharmacy
Department, Teaching Hospital of Chengdu University of
TCM) was administered by gavage at 0.3 g/kg, 0.6 g/kg, and
1.2 g/kg once daily to the low-dose, medium-dose, and
high-dose groups, respectively. Guinea pigs in the model
group were administered 1 mL of distilled water. The con-
trol group did not receive any treatment.
Diopter and axial length measurements
Diopter and axial length of the right eye were measured in
all guinea pigs at baseline and immediately after the right
eye was uncovered at the end of the experimental period.
Eyedrops containing 1% tropicamide were given in the
right eyes (1/5 min, four times) before optometry in a
darkroom by the same optometrist using a streak retino-
scope and trial lenses. The refraction was recorded as the
mean value of the horizontal and vertical meridians based
on three repeated measurements. The guinea pigs were
then treated with the anesthetic 0.4% oxybuprocaine (1/
5 min, 2e3 times) on the conjunctival sac of their right
eyes and the axial length of the right eyes were manually
measured three times by ultrasonography (BME-210 A/B
Ophthalmic Ultrasound System, MEDA, Tianjin, China) to
an accuracy of 0.01 mm. Mean values were calculated for
analysis.
Scleral tissue morphologic observations
Right eyes of all animals were enucleated under deep
anesthesia (1000 mg/kg 20% urethane sodium injected
126 Y. Mo et al.intraperitoneally), and one right eye from each group was
randomly selected. Sclera were removed on a cold clean
working table by careful dissection, stored in liquid nitro-
gen at 70C for future real-time polymerase chain reac-
tion (RT-PCR) detection. The remaining 12 right eyes of
each treatment group were removed with 1e2-mm optic
nerve tissue with a small limbus triangle incision and put in
an ethanoleformaldehydeeacetic acid solution for 1 week
of fixation. The ocular tissue on the coronal plane con-
taining the optic nerves was removed with sections 3e5 mm
in thickness. After gradient ethanol dehydration and
paraffin embedding, three 4-mm sections were made, and
one was used for HE staining. Each layer of the ocular tissue
structure was observed under a low power field (100) light
microscope, and the scleral thickness, the quantity of
scleral fibroblasts, and the degree of collagen fiber align-
ment were observed under a medium power field (200).
Five visual fields of sclera at both ends of the optic disk
were used for semi-quantitative measurements of scleral
full-thickness in each group using an image analysis system
(Mias-2000, WiseSoft, Chengdu, Sichuan, China), 10 times
for each visual field. The scleral thickness was calculated as
the mean of these 100 measurements. To exclude the
impact of artificial fissures created during preparation of
the tissue slices on scleral thickness measurements, the
above-mentioned 10 visual fields of scleral tissue full-
thickness areas were measured again. Taking the sum of
10 visual fields within the measured area expresses the
thickness of sclera. The integral optical density (IOD) of
fiber cell nuclei in these 10 visual fields inside the scleral
tissue was also measured twice. The sum of the fiber cell
nuclei IOD in the 10 visual fields showed the quantity of
fibroblasts.
Immunohistochemistry testing of scleral TGF-b1 and
Smad3 expressions
Scleral TGF-b1 and Smad3 expressions were tested by the
immunohistochemistry (IHC) streptavidineperoxidase (SP)
method using two tissue slices. Analysis was performed
using rabbit-anti-mouse TGF-b1 (V) polyclonal antibody
(Santa Cruz Biotechnology, Dallas, TX, USA), goat-anti-
mouse Smad3 (I-20) polyclonal antibody (Santa Cruz
Biotechnology), and secondary antibodies and correspond-
ing IHC kits (ZSGB-BIO, Beijing, China). The assays,
including positive and negative controls, DAB color devel-
opment, hematoxylin counterstaining, and sealing were
performed according to the manufacturer’s instructions.
Positive staining was assessed if the sections contained
yellow or brown regions that appeared as fine or silk-likeTable 1 Primer sequences for real-time polymerase chain reac
Gene Bi-directional primer sequences A
GAPDH F:50-GAAGGTCGGAGTGAACGGA-30
R:50-TACTGGAGGTCAATGAAGGGAT-30
6
TGF-b1 F:50-TAGAGGGCTTTCGCTTCAGTG-30
R:50-TCCTTGCGGAAGTCAATGTAGA-30
6
Smad3 F:50-CTGGTGCCACGCCATACA-30
R:50-CATCTGGTGGTCACTGGTTTCT-30
6particles. We found that TGF-b1 and Smad3 were expressed
in the scleral fiber cytoplasm and ECM. First, each layer of
ocular tissue structure was observed under a low power
field (100) light microscope and then the TGF-b1 and
Smad3 staining patterns were observed under a medium
power field (200). Five visual fields of sclera were chosen
at both ends of the optic disk for a total of 10 visual fields.
The TGF-b1 and Smad3 staining, appearing yellow and
brown, were split by color. A semi-quantitative IOD mea-
surement of TGF-b1 and Smad3 staining in the 10 visual
fields of sclera was performed using an image analysis sys-
tem, and the sum of the IODs was used to assess the levels
of TGF-b1 and Smad3.
Real-time polymerase chain reaction
Scleral TGF-b1 and Smad3 mRNA expression was tested by
RT-PCR with tissue from the saved right eye of each group.
First, total cellular RNA was extracted using TRIZOL (Invi-
trogen, Carlsbad, CA, USA), and the IOD of each sample was
measured by UV spectrophotometry to assess RNA purity.
After electrophoretic separation, the RNA samples showed
three bands from top to bottom: 28S, 18S, and 5S, of which
the brightness of 28S was twice that of 18S, demonstrating
the integrity of the extracted RNA. Samples with an A260/
A280 ratio between 1.8 and 2.1 were selected for further
analysis.
Primer design was carried out using software based on
the gene sequences available through the GenBank website
(National Institutes of Health, Bethesda, MD, USA). We used
a two-step method RT-PCR kit for RT-PCR amplification.
Target gene primer synthesis (both design and synthesis)
were completed by KangChen Bio-tech (Shanghai, China)
(Table 1).
RT-PCR was carried out using various target and house-
keeping genes. The concentrations of these control
genes and house-keeping genes were directly generated
using a gradient dilution DNA standard curve. All test re-
sults were repeated three times to generate a baseline
and threshold to allow determination of the Ct value.
2  DDCt was determined using the formula DCt Z [Ct
(target gene)]  [Ct (reference gene)] and DDCt Z [DCt
(treatment group)]  [DCt (control group)]; namely the
fold of target gene expression index in the treatment
group relative to the control group.11
Statistical analysis
Data were processed using SPSS17.0 statistical software
(IBM, Armonk, NY, USA) and are expressed as mean (SD).tion.
nnealing temperature (C) Length of products (bp)
0 114
0 274
0 174
Scleral TGF-b1 and Smad3 expression 127Normal distribution and Levene’s homogeneity test of var-
iances were also performed. Diopters were compared
among groups before and after treatment using the paired
t-test, and changes in diopter and the axial length among
groups were analyzed by one-way ANOVA. The homogeneity
of variances was measured with the least significant dif-
ference test, and the heterogeneity of variance was
measured by Dunnett’s test; P < .05 indicated differences
between samples were statistically significantly (see
Tables 2, 3 and 4).Results
Diopter and axial length
There were no differences in baseline diopter variance
among the groups (F Z 1.006, P Z .413). However, at the
end of the experiment, the final diopters in the model
group were significantly greater than those of the control
group, and the final diopters in the Bu Jing Yi Shi groups
were significantly less than in the model group (F Z 6.176,
P Z .001). Baseline axial lengths among groups were not
statistically different (F Z 0.507, P Z .731), but the final
axial lengths in the model group were markedly greater
than the control group, while the final axial lengths in the
Bu Jing Yi Shi groups were significantly less than the model
group (F Z 12.774, P Z .001).Table 2 Diopter comparison among groups.a
Groups (n) Initial diopter (DS) Final diopter (DS
Control (13) 1.54  1.19 0.98  0.72
Model (13) 1.13  0.97 1.02  0.88b
Low-dose (13) 1.10  1.13 0.36  1.45c
Medium-dose (13) 1.73  0.83 0.25  1.49c
High-dose (13) 1.00  1.29 0.46  1.16c
F 1.006 6.176
P .413 .001
a Values expressed as mean (SD) unless otherwise indicated.
b P < .01 vs. control group.
c P < .01 vs. model group.
Table 3 Comparison of scleral thickness, fibroblasts, and area
Groups (n)a Scleral thickness (mm)
Control (12) 39.42  4.69
Model (12) 37.58  5.40
Low-dose (12) 40.87  5.47
Medium-dose (12) 44.63  3.86c
High-dose (12) 41.38  3.26d
F 3.838
P .008
a 12 right eyes measured in each group.
b P < .01 vs. control group.
c P < .01.
d P < .05 vs. model group.Scleral thickness, area, and fibroblasts
Hematoxylin and eosin stained slices of guinea pig right
sclera tissue were observed under a microscope. In the
control group, scleral thickness was moderate, fibroblasts
were apparent and had an even distribution, and the
scleral fibroblasts and fiber alignment were arranged in an
orderly manner (Fig. 1A). In the model group, scleral
thickness had become thin, with few fibroblasts that
distributed unevenly, and the scleral fibroblasts and fiber
alignment were disordered (Fig. 1B). In the low-, medium-
, and high-dose Bu Jing Yi Shi groups, compared with the
model group, scleral thickness had increased, fibroblasts
were increased to varying degrees and were more evenly
distributed, and scleral fibroblasts and fiber alignment
were also more evenly distributed (Fig. 1CeE). Differences
in scleral thickness, area, and fibroblasts among the Bu
Jing Yi Shi groups were significant (scleral thickness:
F Z 3.84, P Z .001; scleral area: F Z 12.76, P Z .001;
scleral fibroblasts: FZ 22.17, PZ .001). Scleral thickness
in the model group was reduced compared with the con-
trol group but the difference was not statistically signifi-
cant (P > .05). Using the scleral area to express scleral
thickness, thereby excluding artificial fractures in the
slice, the scleral area in the model group was significantly
less than that of the control group (P < .01). The sum of
scleral area in each treatment group was significantly
higher than that of the model group (P < .01). The scleral) Initial axial length (mm) Final axial length (mm)
8.43  0.28 8.64  0.24
8.48  0.17 9.84  0.79b
8.54  0.18 8.78  0.55c
8.47  0.16 8.87  0.39c
8.48  0.16 8.55  0.36c
0.507 12.774
.731 .001
among groups.
Number of scleral fibroblasts Scleral area (mm2)
17846.9  5330.7 50725.5  18956.3
10781.1  2803.1b 26988.5  6234.6b
28407.9  3609.7c 58367.5  8240.2c
28782.8  9573.3c 63937.2  19488.1c
20743.9  3775.8c 50085.2  9274.5c
22.170 12.785
.001 .001
Figure 1 Scleral histomorphology among groups. White arrows indicate the sclera and black arrows indicate fibroblasts. A: In the
control group, the scleral collagen fibers were aligned in an orderly manner and fibroblast arrangement was uniform. B: In the
model group, the scleral collagen fibers were disordered and fibroblasts were decreased and disordered. CeE: In the low-, medium-,
and high-dose treatment groups, the scleral collagen fibers were orderly and fibroblasts were increased to varying degrees and
orderly.
128 Y. Mo et al.fibroblasts in the model group were markedly less than
that of the control group (P < .01) and increased in the
animals in the treatment groups (P < 0.01).
Scleral TGF-b1 and Smad3 expressions among
groups
TGF-b1- and Smad3-stained right ocular slices were
observed under a microscope. TGF-b1 immunohistochem-
istry was performed using the SP method, TGF-b1 and
Smad3 staining appeared as yellow or brown fine particle-
or fine silk-like structures and were observed in scleral
fibroblast cells and in the ECM. In the control group,
staining was distributed uniformly and widely in the sclera.
In contrast, in the model group, immunoreactive areas
were sparse, limited to a small range showing uneven dis-
tribution, and appeared light yellow or yellow. In the Bu
Jing Yi Shi groups, Smad3 staining was uniformly intense
and widely distributed to different degrees in the sclera.
Using IOD values from stained sections, we found differ-
ences in the levels of TGF-b1 and Smad3 among the
different groups (TGF-b1 IOD: F Z 7.986, P Z .001; Smad3
IOD: F Z 4.799, P Z .001). TGF-b1 IOD in the model group
was significantly lower than in the control group and low-,
medium-, and high-dose groups (P < .01). Smad3 IOD in the
model group was also significantly lower than in the control
group and medium- and high-dose groups (P < .05 and
P < .01, respectively) (Figs. 2 and 3, Table 4).
Scleral TGF-b1 and Smad3 mRNA expressions
among groups
RT-PCR was used to determine the expressions of TGF-b1
and Smad3 mRNA (2DDCt method; Tables 5 and 6). Results
revealed that scleral TGF-b1 and Smad3 mRNA in the modelgroup were decreased compared with the negative control
group, but were increased concomitant with increase in Bu
Jing Yi Shi dose in the treatment groups.
Discussion
Reduced scleral collagen content is associated with the
formation of myopia.12 This study used 3-week-old guinea
pigs in which FDM was induced in the right eye. The final
diopter and axial length at conclusion of the study were
significantly less and greater, respectively, than in the
control group. These results validate the FDM model. The
final diopter and axial length in the treatment groups were
significantly greater and less, respectively, than in the
model group. These results indicate that the Chinese
medicine Bu Jing Yi Shi Tablets appears to intervene in the
formation of myopia. The sclera plays an important role in
maintaining the axial length and the depth of the vitreous
chamber during the formation of myopia. Previous studies
have shown that in human myopia, the sclera thins, the
collagen content decreases significantly, the diameter and
tissue of collagen fibers alter, and the dry weight of the
sclera decreases.12e15 In mammals, the sclera is mainly
composed of a small number of fibroblasts and a large
amount of ECM. Collagen is the main component of the ECM
and accounts for 90% of the dry weight of the sclera and is
produced by fibroblasts. Scleral fiber is mainly made up of
collagen I and small amounts of collagens III and IV.16 It is
widely recognized that genetic and environmental factors
cause abnormal production and degradation of scleral
collagen, causing scleral thinning. When the sclera be-
comes too weak for normal intraocular pressure and
expansion it leads to excessive axial extension. In the
induced myopia model, collagen synthesis is reduced when
mitotic activity of fibroblasts is diminished. During scleral
remodeling, collagen I expression decreases significantly,17
Figure 3 Scleral Smad3 expression among groups. White arrows indicate the sclera and black arrows indicate Smad3 staining;
Smad3 immunohistochemistry was performed with SP method and all images were obtained at 400 magnification. A: Smad3
staining was intensely visible as yellow or brown fine particle- or silk-like structures in the control group; B: Smad3 staining was
sparse, found in only a small range with uneven distribution and appeared light yellow or yellow in the model group. CeE: Smad3
staining was uniform and intensively and widely distributed to different degrees in the sclera of the treatment groups (C, low-dose;
D, medium-dose; E, high-dose).
Figure 2 Scleral TGF-b1 expression among groups. White arrows indicate the sclera and black arrows indicate TGF-b1 staining;
TGF-b1 immunohistochemistry was performed with the SP method and all images were obtained at 400 magnification. A: TGF-b1
staining was intensely visible as yellow or brown fine particle- or fine silk-like structures in the control group; B: TGF-b1 staining
was sparse, found in only a small range with uneven distribution and appeared light yellow or yellow in the model group (black
arrow). CeE: TGF-b1 staining was uniform and intensively and widely distributed to different degrees in the sclera of the treatment
groups (C, low-dose; D, medium-dose; E, high-dose).
Scleral TGF-b1 and Smad3 expression 129but the degradation of collagen fibers and ECM increases.
ECM is mainly synthesized by scleral fibroblasts.18 In our
study, we observed that the number of scleral fibroblasts in
the model group decreased significantly compared with the
control group and scleral thickness in the model group was
decreased compared with the control group. Thus, myopia
in the model group may be due to altered fibroblast pro-
liferation and a decrease in the number of fibroblasts
causing reduced collagen synthesis and ultimately scleral
thinning.After treatment with Bu Jing Yi Shi Tablets, the number
of scleral fibroblasts in each treatment group was signifi-
cantly increased, as was the thickness of the sclera, sug-
gesting this treatment can increase fibroblast proliferation
and cell number, leading to increased collagen synthesis,
scleral thickening, and prevention of axial extension, to
attenuate development of myopia.
The transforming growth factor super-family members
are multifunctional cytokine growth factors that regulate
cellular processes, differentiation, organ formation, and
Table 4 Levels of TGF-b1 and Smad3 among groups.a
Groups (n)b TGF-b1 Smad3
Control (12) 2910.04  494.68 2597.67  668.28
Model (12) 2044.28  471.71c 1764.75  479.90c
Low-dose (12) 2439.50  696.02 2190.33  540.76
Medium-dose (12) 2893.62  541.98d 2270.25  579.02e
High-dose (12) 3194.68  549.97d 2680.50  600.72d
F 7.986 4.799
P .001 .001
a Values expressed as mean (SD) unless otherwise indicated.
b 12 right eyes assessed in each group.
c P < .01 vs. control group.
d P < .05 vs. model group.
e P < .01 vs. model group.
130 Y. Mo et al.apoptosis. TGF-b promotes the formation of ECM and in-
hibits cell proliferation. In mammals, TGF-bs exist in three
forms, TGF-b1, TGF-b2, and TGF-b3. Of these, TGF-b1 is
the most highly expressed, the most active and the most
widely distributed and can modulate remodeling of ECM.
TGF-b1 is involved in modulating scleral remodeling during
the formation of myopia. TGF-b1 expression decreases
significantly during the formation of myopia.19,20 An in-
crease in TGF-b1 will increase collagen expression and
protein synthesis. TGF-b1 relies on the involvement of
Smads during synthesis of ECM.21 The Smad3 signaling
pathway can regulate the activity of TGF-b, while the
activity of Smad3 itself is mediated by phosphorylation
and cytoplasm-nuclear translocation.22 Smads are also
critical for the downstream processes of TGF-b. Smad
proteins will translocate to the cell nucleus and promote
the transcription of TGF-b targets. Function of the Smad3
signaling pathway is directly related to the remodeling of
the cytoskeleton and plays an important role in cellular
morphologic changes and formation of stress fibers.Table 5 Scleral TGF-b1 mRNA expressions among groups.
Groups Target gene average Ct Reference ge
Control 25.73733 20.46105
Model 23.78853 19.93468
Low-dose 25.36595 20.14128
Medium-dose 24.40384 20.27015
High-dose 22.91045 20.58630
Table 6 Scleral Smad3 mRNA expressions among groups.
Groups Target gene average Ct Reference ge
Control 24.40298 20.46105
Model 23.47434 19.93468
Low-dose 24.26181 20.14128
Medium-dose 23.29889 20.27015
High-dose 22.35261 20.58630
In the experiment, the amount of target sequence in the samples w
quantity of references (control group). Therefore, the reference (cont
in the reference.Additionally, TGF-b1 induces the phosphorylation of
Smad3 to induce the Smad3 signaling pathway. Thus,
remodeling of the cytoskeleton is controlled by TGF-b1
mediated by Smad3.23
Expression of cytoskeleton is differ to myopia versus
normal, the protein involved in actin cytoskeleton was
downregulation in lens-induced myopia sclera.24 We found
that scleral TGF-b1 and Smad3 in the model group were
significantly reduced, and TGF-b1 and Smad3 mRNA were
also decreased compared with the control group. The re-
sults suggest that myopia formation is accompanied by a
reduction in the transcription of the TGF-b1 and Smad3
genes and potentially protein as well. Fibroblast division
decreases and collagen synthesis is reduced through
diminished TGF-b1/Smad3 signaling, resulting in scleral
thinning that cannot tolerate normal intraocular pressure,
which induces ocular expansion and axial extension and
thus formation of myopia.
After treatment with Bu Jing Yi Shi Tablets, scleral TGF-
b1 and Smad3 protein levels in the medium- and high-dose
groups were significantly increased compared with the
model group. Expression of scleral TGF-b1 and Smad3 mRNA
was increased in the low-, medium-, and high-dose groups.
These results show that this herbal intervention can in-
crease TGF-b1 and Smad3 transcription and protein syn-
thesis in scleral fibroblasts. Fibroblast division and collagen
synthesis increase through the TGF-b1/Smad3 signaling
pathway, allowing for scleral thickening, which can with-
stand normal intraocular pressure to prevent ocular over-
extension and myopia formation.
In Chinese medicine theory, each sensory organ is asso-
ciated with an internal organ. The eyes are directly asso-
ciated with the liver with the kidneys and other organs
playing supportive roles to the liver. Thus, in treating eye
disorders, the TCM strategy is to address any disharmonies
of the liver and kidneys. The herbal ingredients in Bu Jing Yi
Shi Tablets are widely used in China in various formulations
to treat eye disorders. The tablets include L. barbarum,ne average Ct DCt DDCt 2DDCt
5.27628 0 1
3.85385 1.42243 0.385
5.22467 0.05161 0.396
4.13369 1.14259 0.828
2.32415 2.95218 2.832
ne average Ct DCt DDCt 2DDCt
3.94193 0 1
3.53966 0.40227 0.774
4.12053 0.17860 0.679
3.02874 0.91319 1.419
1.76631 2.17562 3.316
as determined from the standard curve and was divided by the
rol group) is 1 and other samples are n times the amount of sample
Scleral TGF-b1 and Smad3 expression 131Cuscuta chinensis, Salvia miltiorrhiza, Plantago seed, P.
notoginseng, and green tangerine peel, et al. In traditional
Chinese medicine literature, L. barbarum can nourish liver
and kidney, enrich essence and blood and improve eyesight.
C. chinensis tonifies the liver, kidneys, and spleen. S. mil-
tiorrhiza is commonly prescribed to prompt blood circula-
tion, nourish the blood, and remove blood stasis. Plantago
seed is often used to treat eye problems due to liver and
kidney deficiency. P. notoginseng is effective in the relief of
blood stasis and can reduce swelling and relieve pain.
Green tangerine peel is prescribed to dispel clumped liver
qi and spread liver qi. All of them can nourish the liver and
kidneys and improve eyesight. According to recent studies,
L. barbarum main active components are L. barbarum
polysaccharides (LBP), which can reduce neuronal damage,
blood-retinal barrier disruption and oxidative stress in
retinal ischemia/reperfusion injury.25 It is a cytoprotective
agent against retinal pigment epithelial (RPE) cell
apoptosis.26 LBP can increase the survival rate and promote
the growth of mixed cultured rat retinal ganglion cells
(RGC).27 C. chinensis has anti-oxidation action.28 Its ex-
tracts can inhibit apoptosis and has the function of neuro-
trophine.29 Different doses of C. chinensis Lam. medicated
serum can promote cell proliferation and increase expres-
sions of Collagen IImRNA and protein.30 Collagen fiber
structure across the posterior sclera.31 Maybe C. chinensis
can increase expression of collagen protein in myopia
sclera. S. miltiorrhiza active component tanshinone has
protective effect on rat neural stem cell damage, and can
decrease the formation of free radicals, inhibit peroxidatic
reactions, protect neural stem cell against both hypoxia
damage and oxidant damaged.32 The danshensu could
significantly decrease the percentage of neuronal apoptosis
and necrosis, increase mitochondrion membrane potential
(MMP) and mitochondrion activity,33 and improve blood
circulation.34 Plantago seed possess biological activities
including anti-lens epithelial cell apoptosis and antioxi-
dant.35 Plantain seed polysaccharide (PSP) can affect the
defensive function of rat liver mitochondria and play a
certain role in “prevention of disease”.36 Green tangerine
peel decoction can relax the uterine smooth muscles37 and
colonic smooth muscles.38 It is known that the ciliary
muscle is made of smooth muscle too.39 Myopia study shows
that a thicker posterior region of the ciliary muscle was
associated with increased myopic refractive error.40,41 The
active component of P. notoginseng is P. notoginseng sa-
ponins (PNS) including anticoagulant activity.42 Study
demonstrates the biennial flower of PNS to have neuro-
protection effect on cultured neurons and the underlying
protection mechanism may involve anti-oxidation.43 PNS
can protect against cisplatin-induced nephrotoxicity and
reduce renal tissue apoptosis via inhibiting the mitochon-
drial pathway.44 Studies of myopia showed that oxidant
stress associated with eye diseases of myopia,45 thicker
ciliary muscle,40,41 scleral and choroidal thinning,46 poste-
rior staphyloma formation,47 retinal neuronal apoptosis,48
significantly lower pulsatile ocular blood flow.49 Studies of
above herbs showed that the Bu Jing Yi Shi Tablets can
relieve the early ciliary muscle spasm of myopia, improve
the activity of scleral collagen fiber, increase collagen
levels, enhance regional blood flow, resist oxidation, inhibit
RPE and RGC apoptosis.Conclusion
Treatment of form-deprivation myopia in guinea pigs with
the Chinese herbal medicine Bu Jing Yi Shi Tablets
improved scleral fibroblast TGF-b1 and Smad3 transcription
and increased TGF-b1 and Smad3 protein synthesis. Fibro-
blast division and collagen synthesis increased through
restored TGF-b1/Smad3 signaling, resulting in scleral
thickening to allow tolerance of normal intraocular pres-
sure and prevent ocular over-extension. Thus, we speculate
that Bu Jing Yi Shi Tablets counteracts the deterioration
that occurs during myopia formation.Acknowledgments
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